Studies have shown that NCAPG is involved in the pathogenesis of a variety of cancers, including prostate cancer [6], paediatric glioma [30], renal cell carcinoma [31], multiple myeloma [32] and melanoma [33]. This evidence concerns the gene NCAPG and plasma cell myeloma.